American Association of Chairs of Departments of Psychiatry Report issue

Foundation

Organization Overview

First Clinical Trial
2007
NCT00600145
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

mirtazapine (remeron) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1